Vetanco at the Vaccine Technology Summit 2022 in London

Published 14/09/2022 in category Events/News

The laboratory will be present at the Vaccine Technology Summit 2022 Exhibition & Conference, to be held in London on September 15 and 16

Within the framework of its international position as a leader in scientific innovation, Vetanco, the international veterinary laboratory that has been developing, manufacturing, and selling innovative products for animal health and production for 35 years, will participate in the Vaccine Technology Summit 2022 to be held at the Hilton Kensington, London, United Kingdom, on September 15-16, 2022. There, Sherry Layton, Ph.D. Chief Scientific Director of Vetanco and BV Science, will lead the discussion on Immune System Preprogramming/ Reprogramming.

Vetanco at the Vaccine Technology Summit 2022 in London

The Vaccine Technology Summit 2022 is the only event to offer leading market intelligence and industry presentations on the latest vaccine technologies and techniques for discovering, developing, and manufacturing next-generation vaccines.

It is aimed at leading pharmaceutical and biotech companies, vaccine developers, and groups of politicians and government experts seeking to learn more about new vaccine technologies and technical knowledge to discover, develop, and manufacture new vaccines to tackle global outbreaks.

The Vaccine Technology Summit 2022 will allow professionals involved in relevant disciplines to report on their achievements and exchange views. Furthermore, the event will focus exclusively on networking and new relationships, including creating a discussion on know-how for the vaccine industry. It will also become an opportunity to integrate with leading pharmaceutical and biotech companies and demonstrate their knowledge of new technologies and techniques for vaccine development.

“We are very proud to attend these major international events in terms of technology and innovation in vaccines, through the presentation of our Chief Scientific Director of Vetanco and BV Science”, they reported from the company.

Presentations will focus on new vaccine technologies, clinical trials, manufacturer case studies, and new market data for current and future vaccination initiatives. An exclusive networking opportunity will also be developed to connect with other professionals with shared challenges and experiences in this rapidly evolving sector. Updates will be shared on regional projects and research led by leading vaccination experts and manufacturers describing their experiences, findings, and new proposals.

To learn more about the event, visit:


Leave your comment

nineteen + five =

View all news